Skip to main content
Top
Published in: European Journal of Epidemiology 11/2018

Open Access 01-11-2018 | DATA RESOURCES

A population based pediatric oncology registry in Southern Sweden: the BORISS registry

Authors: Thomas Wiebe, Lars Hjorth, Mercedes Marotta Kelly, Helena M. Linge, Stanislaw Garwicz

Published in: European Journal of Epidemiology | Issue 11/2018

Login to get access

Abstract

A population based registry, with the acronym BORISS, was established. It contains all individuals (0–18 years of age at diagnosis) diagnosed with cancer from 1970–01–01 until 2016–12–31 in Southern Sweden. The treatment data has been entered into the registry after confirmation of the diagnosis by the Swedish national cancer registry and updates on vital status from the Swedish population registry. The number of individuals with a pediatric cancer diagnosed during these 46 years are 2928. Of these, 2065 are currently alive and 1882 individuals are 5-year survivors. Data on treatment and malignancy of the 5–year survivors has been collected from medical records and entered into the database. Treatment data contains surgical procedure, target organ of radiation therapy including dose and fractionation, and cytostatic treatment with dose (mg) per body surface area (m2) for all cytostatic agents. Data on individuals receiving stem cell treatment is included. The database is unique in that it is population based, contains all individuals and detailed treatment data on all 5-year survivors after childhood cancer in Southern Sweden since 1970. The database has contributed to several academic theses in the field of late effects after childhood cancer. BORISS also supports the Late Effect Clinic at Skåne University Hospital in Lund, Sweden with treatment details enabling a stratified surveillance.
Literature
1.
go back to reference Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5–a population-based study. Lancet Oncol. 2014;15(1):35–47.CrossRef Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5–a population-based study. Lancet Oncol. 2014;15(1):35–47.CrossRef
2.
go back to reference Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–82.CrossRef Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–82.CrossRef
3.
go back to reference Hjorth L, Haupt R, Skinner R, Grabow D, Byrne J, Karner S, et al. Survivorship after childhood cancer: PanCare: a European Network to promote optimal long-term care. Eur J Cancer. 2015;51(10):1203–11.CrossRef Hjorth L, Haupt R, Skinner R, Grabow D, Byrne J, Karner S, et al. Survivorship after childhood cancer: PanCare: a European Network to promote optimal long-term care. Eur J Cancer. 2015;51(10):1203–11.CrossRef
4.
go back to reference Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer, third edition. Cancer. 2005;103(7):1457–67.CrossRef Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer, third edition. Cancer. 2005;103(7):1457–67.CrossRef
5.
go back to reference Mörse H. Anti-Müllerian hormone as a marker of ovarian reserve in girls before, during and after treatment for childhood cancer. Doctoral Thesis (compilation). Lund: Lund University, Faculty of Medicine; 2017. Mörse H. Anti-Müllerian hormone as a marker of ovarian reserve in girls before, during and after treatment for childhood cancer. Doctoral Thesis (compilation). Lund: Lund University, Faculty of Medicine; 2017.
6.
go back to reference Romerius P. Reproductive function in male childhood cancer survivors. Doctoral Thesis (compilation). Lund: Lund University, Faculty of Medicine; 2010. p. 137. Romerius P. Reproductive function in male childhood cancer survivors. Doctoral Thesis (compilation). Lund: Lund University, Faculty of Medicine; 2010. p. 137.
7.
go back to reference Follin C. Late complications of childhood acute lymphoblastic leukaemia (ALL), with special reference to hormone secretion, cardiovascular risk and bone health. Doctoral Thesis (compilation). Lund: Lund University, Faculty of Medicine; 2010. p. 142. Follin C. Late complications of childhood acute lymphoblastic leukaemia (ALL), with special reference to hormone secretion, cardiovascular risk and bone health. Doctoral Thesis (compilation). Lund: Lund University, Faculty of Medicine; 2010. p. 142.
8.
go back to reference Einarsson E-J. Late effects on hearing and balance after treatment for childhood cancer. Doctoral Thesis (compilation). Lund: Lund University, Faculty of Medicine Otorhinolaryngology, Clinical Sciences; 2014. p. 198 Einarsson E-J. Late effects on hearing and balance after treatment for childhood cancer. Doctoral Thesis (compilation). Lund: Lund University, Faculty of Medicine Otorhinolaryngology, Clinical Sciences; 2014. p. 198
9.
go back to reference Grabow D, Kaiser M, Hjorth L, Byrne J, Alessi D, Allodji RS, et al. The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries. Eur J Epidemiol. 2018;33(3):335–49.CrossRef Grabow D, Kaiser M, Hjorth L, Byrne J, Alessi D, Allodji RS, et al. The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries. Eur J Epidemiol. 2018;33(3):335–49.CrossRef
10.
go back to reference Asdahl PH, Winther JF, Bonnesen TG, De Fine Licht S, Gudmundsdottir T, Anderson H, et al. The Adult Life After Childhood Cancer in Scandinavia (ALiCCS) study: design and characteristics. Pediatr Blood Cancer. 2015;62(12):2204–10.CrossRef Asdahl PH, Winther JF, Bonnesen TG, De Fine Licht S, Gudmundsdottir T, Anderson H, et al. The Adult Life After Childhood Cancer in Scandinavia (ALiCCS) study: design and characteristics. Pediatr Blood Cancer. 2015;62(12):2204–10.CrossRef
11.
go back to reference Armenian SH, Landier W, Hudson MM, Robison LL, Bhatia S. COG Survivorship and Outcomes Committee. Children’s Oncology Group’s 2013 blueprint for research: survivorship and outcomes. Pediatr Blood Cancer. 2013;60(6):1063–8.CrossRef Armenian SH, Landier W, Hudson MM, Robison LL, Bhatia S. COG Survivorship and Outcomes Committee. Children’s Oncology Group’s 2013 blueprint for research: survivorship and outcomes. Pediatr Blood Cancer. 2013;60(6):1063–8.CrossRef
Metadata
Title
A population based pediatric oncology registry in Southern Sweden: the BORISS registry
Authors
Thomas Wiebe
Lars Hjorth
Mercedes Marotta Kelly
Helena M. Linge
Stanislaw Garwicz
Publication date
01-11-2018
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 11/2018
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-018-0437-1

Other articles of this Issue 11/2018

European Journal of Epidemiology 11/2018 Go to the issue